Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated page revision label to include Revision: v3.4.3 and remove Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:13:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; notices about government funding and the prior revision (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:51:55.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page template to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:28:57.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a 'Show glossary' feature and updated footer/labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the revision to v3.4.0. The changes are cosmetic and do not modify the study information.
    Difference
    0.2%
    Check dated 2026-01-28T06:01:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:46:10.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations now appear under the study details with a Washington site listed. The page update changes the revision from v3.3.2 to v3.3.3 and removes the Washington Locations and HHS Vulnerability Disclosure items from the footer area.
    Difference
    0.2%
    Check dated 2025-12-23T09:46:59.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.